China CAS:35380-71-3 Manufacturer

We hold strengthening and perfecting our items and repair. At the same time, we get the job done actively to do research and progress for CAS:35380-71-3, We welcome new and aged buyers from all walks of lifetime to make contact with us for potential small business associations and mutual success!
CAS:35380-71-3, Our company warmly invites domestic and overseas customers to come and negotiate business with us. Let us join hands to create a brilliant tomorrow! We're looking forward to cooperating with you sincerely to achieve a win-win situation. We promise to try our best to supply you with high quality and efficient services.

Hot Products

  • Levonorgestrel

    Levonorgestrel

    Levonorgestrel has speficications of CP/EP/USP. DMF,GMP and CEP available.

    CAS:797-63-7

  • Testosterone

    Testosterone

    Testosterone has CP,EP and USP specifications. CEP, DMF, WC, FDA available..

    CAS:58-22-0

  • Eplerenone

    Eplerenone

    Eplerenone has EP specifications. CEP available and FDA approved.

    CAS:107724-20-9

  • Mirabegron

    Mirabegron

    Mirabegron has In-house specification. DMF approved..

    CAS:223673-61-8

  • 16-Dehydropregnenolone Acetate (16-DPA)

    16-Dehydropregnenolone Acetate (16-DPA)

    16-Dehydropregnenolone Acetate (16-DPA) is the dehydration product of Pregnenolone Acetate..

    CAS:979-02-2

  • Abiraterone

    Abiraterone

    Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), It is used in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has already spread to other parts of the body) and metastatic high-risk castration-sensitive prostate cancer.

    CAS:154229-19-3

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept